Stocksigma LogoStocksigma Logo

Trident Texofab Q2 FY27 Financial Results Show Revenue and Profit Decline

Trident Texofab reported standalone revenue from operations of ₹2,533.77 lakh for the quarter ended 30th Sep'26, down 17.29% YoY from ₹3,063.46 lakh and

Trident Texofab Q2 FY27 Financial Results Show Revenue and Profit Decline

Trident Texofab Ltd · Financial Result · 06 Nov 2026, 2:59 am

Trident Texofab Q2 FY27 Financial Results Show Revenue and Profit Decline Trident Texofab reported standalone revenue from operations of ₹2,533.77 lakh for the quarter ended 30th Sep'26, down 17.29% YoY from ₹3,063.46 lakh and down 3.08% QoQ from ₹2,614.26 lakh. Net profit for the period dropped 46.44% YoY to ₹60.40 lakh from ₹112.77 lakh, though it rose 15.75% QoQ from ₹52.18 lakh. Diluted EPS stood at ₹0.40 compared to ₹0.74 in Q2 FY26. For H1 FY27, revenue fell 12.31% YoY to ₹5,148.03 lakh, while net profit halved to ₹112.57 lakh from ₹214.38 lakh.

Original exchange filing (PDF)

More announcements from Trident Texofab Ltd

All Trident Texofab Ltd announcements